Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in AURA — Aura Biosciences, Inc.

CIK 1115418 BOSTON, MA
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$451,964
+$18,988 QoQ
Shares Held
63,657
-1.6% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 146 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 31% Shared 0% None 69%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. AURA ranks #192 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in AURA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $451,964 63,657
2026-03-31 $432,976 64,720
2025-12-31 $354,435 65,034
2025-09-30 $426,648 69,037
2025-06-30 $409,447 65,407
2025-03-31 $375,262 64,038
2024-12-31 $605,148 73,619
2024-09-30 $658,342 73,888
2024-06-30 $479,931 63,483
2024-03-31 $356,955 45,472
2023-12-31 $353,363 39,883
2023-09-30 $359,392 40,066
2023-06-30 $490,010 39,677
2023-03-31 $276,423 29,787
2022-12-31 $238,035 22,670
2022-09-30 $404,782 22,339
2022-06-30 $293,503 20,713